Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Wong, H. [1 ]
Yau, C. C. [1 ]
Yao, T. [1 ]
Tang, V. [1 ]
Chan, P. [1 ]
Chiu, J. [1 ]
Fan, S. [1 ]
Peon, R. [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14522
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14522
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
    Marta, Guilherme Nader
    da Fonseca, Leonardo G.
    Braghiroli, Maria Ignez
    Moura, Fernando
    Hoff, Paulo M.
    Sabbaga, Jorge
    [J]. CLINICS, 2021, 76 : 1 - 6
  • [2] Efficacy and tolerability of single agent sorafenib in poor risk advanced hepatocellular carcinoma patients
    Yau, T.
    Chan, P.
    Ng, K.
    Chok, K.
    Fan, S. T.
    Poon, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability
    Kostner, Anne Helene
    Sorensen, Morten
    Olesen, Rene Krojgaard
    Gronbaek, Henning
    Lassen, Ulrik
    Ladekarl, Morten
    [J]. SCIENTIFIC WORLD JOURNAL, 2013,
  • [4] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Masayoshi Yada
    Akihide Masumoto
    Kenta Motomura
    Hirotaka Tajiri
    Yusuke Morita
    Hideo Suzuki
    Takeshi Senju
    Toshimasa Koyanagi
    [J]. World Journal of Gastroenterology, 2014, (35) : 12581 - 12587
  • [5] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Yada, Masayoshi
    Masumoto, Akihide
    Motomura, Kenta
    Tajiri, Hirotaka
    Morita, Yusuke
    Suzuki, Hideo
    Senju, Takeshi
    Koyanagi, Toshimasa
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (35) : 12581 - 12587
  • [6] Sorafenib in Elderly Patients with Advanced Hepatocellular Carcinoma: A Case Series
    Montella, Liliana
    Addeo, Raffaele
    Cennamo, Gregorio
    Vincenzi, Bruno
    Palmieri, Rita
    Sperlongano, Pasquale
    Sperlongano, Rossella
    Iodice, Patrizia
    Russo, Paola
    Del Prete, Salvatore
    [J]. ONCOLOGY, 2013, 84 (05) : 265 - 272
  • [7] SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Sacco, P. C.
    De Sanctis, R.
    Quadrini, S.
    Gori, B.
    Del, Signore E.
    Stumbo, L.
    Tedeschi, M.
    Falbo, P. T.
    Fulvi, A.
    Grassi, P.
    Sollami, R.
    Basile, M. L.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [8] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitrios
    Thillai, Kiruthikah
    Korantzis, Ippokratis
    Chowdhury, M. H. Ruhe
    Papadatos-Pastos, Dionysios
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma
    Williet, Nicolas
    Clavel, Lea
    Bourmaud, Aurelie
    Verot, Celine
    Bouarioua, Nadia
    Roblin, Xavier
    Merle, Philippe
    Phelip, Jean-Marc
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 1043 - 1049
  • [10] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitris
    Thillai, Kiruthikah
    Papadatos-Pastos, Dionysios
    Chowdhury, Mahfuja Hussain Ruhe
    Korantzis, Ippokratis
    Manickavasagar, Thubeena
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345